Literature DB >> 3125049

In vitro activity of five new quinolones against cultivable mycobacteria.

S R Pattyn1, D L Van Caekenberghe, J R Verhoeven.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3125049     DOI： 10.1007/bf02014249

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  2 in total

1.  In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.

Authors:  J D Gay; D R DeYoung; G D Roberts
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

Review 2.  Ciprofloxacin: an overview of adverse experiences.

Authors:  P Ball
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790
  2 in total
  4 in total

Review 1.  Mycobacteria and the new quinolones.

Authors:  D C Leysen; A Haemers; S R Pattyn
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

2.  Some pharmacokinetic parameters of pefloxacin in lactating goats.

Authors:  A M Abd El-Aty; A Goudah
Journal:  Vet Res Commun       Date:  2002-10       Impact factor: 2.459

Review 3.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 4.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.